Amarin: Q4 Financial Overview

Amarin Corp. Reports Fourth Quarter Financial Results

Amarin Corp. PLC, headquartered in Dublin, announced on Wednesday that it recorded a net loss of $1.2 million for the fourth quarter.

The company stated that this equates to a loss of less than one cent per share. After adjusting for expenses related to restructuring and stock-based compensation, earnings came to one cent per share.

During the quarter, the biopharmaceutical firm generated $49.2 million in revenue.

Looking at the full year, Amarin's net loss decreased to $38.8 million, or 9 cents per share, with total annual revenue reaching $213.6 million.

Since the start of the year, Amarin's stock price has climbed 11%, and over the past twelve months, shares have gained 35% in value.